You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunogenicity

Showing 26 - 50 of 8,992
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chikungunya Virus Infection Trial (PXVX0317 vaccine booster, Placebo booster)

Not yet recruiting
  • Chikungunya Virus Infection
  • PXVX0317 vaccine booster
  • Placebo booster
  • (no location specified)
Aug 18, 2023

Healthy Volunteers Trial in Changsha (Enterovirus Type 71 Vcacine)

Completed
  • Healthy Volunteers
  • Enterovirus Type 71 Vcacine
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 20, 2023

Rabies Trial in Thai Binh (RABIVAX-S)

Completed
  • Rabies
  • RABIVAX-S
  • Thai Binh, Vietnam
    CDC Thai Binh
Jun 29, 2023

Pneumococcal Disease Trial in Chengdu (23-valent pneumococcal polysaccharide vaccine, control pneumococcal polysaccharide

Recruiting
  • Pneumococcal Disease
  • 23-valent pneumococcal polysaccharide vaccine
  • control pneumococcal polysaccharide vaccine
  • Chengdu, Sichuan, China
    Sichuan Center For Disease Control and Prevention
Sep 19, 2023

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

Chronic Graft-versus-host Disease (cGVHD) Trial in Aventura (AMG 592, Placebo)

Completed
  • Chronic Graft-versus-host Disease (cGVHD)
  • AMG 592
  • Placebo
  • Aventura, Florida
    Research Site
May 16, 2023

Newborn Vaccine Immunogenicity Trial in Fajara, Goroka (Hepatitis B vaccine (HBV), Bacillus Calmette-Guérin (BCG))

Active, not recruiting
  • Newborn Vaccine Immunogenicity
  • Hepatitis B vaccine (HBV)
  • Bacillus Calmette-Guérin (BCG)
  • Fajara, Gambia
  • +1 more
Jan 12, 2023

COVID-19 Trial (CVXGA1)

Not yet recruiting
  • COVID-19
  • CVXGA1
  • (no location specified)
Feb 17, 2023

Immune Response, Safety Trial in Incheon (bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza

Active, not recruiting
  • Immune Response
  • Safety
  • bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine
  • quadrivalent influenza vaccine
  • Incheon, Seo-gu, Korea, Republic of
    International St. Mary's hospital
Jul 28, 2023

COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))

Recruiting
  • COVID-19
  • SARS-CoV-2 DNA Vaccine (ICCOV)
  • Wong Chuk Hang, Hong Kong
    Gleneagles Hospital Hong Kong
Jun 16, 2023

Osteoporosis, Postmenopausal Trial in Yantai (Denosumab)

Recruiting
  • Osteoporosis, Postmenopausal
  • Denosumab
  • Yantai, Shandong, China
    Shandong Boan Biotechnology Co., Ltd.
May 2, 2023

Lymphoma Trial in Houston (PCV20)

Not yet recruiting
  • Lymphoma
  • PCV20
  • Houston, Texas
    M D Anderson Cancer Center
Sep 20, 2023

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

Yellow Fever, Immunization; Infection Trial in Portland (17D)

Not yet recruiting
  • Yellow Fever
  • Immunization; Infection
  • 17D
  • Portland, Oregon
    Oregon Health & Science University
May 10, 2023

Coronavirus Trial (OVX033, Saline solution)

Not yet recruiting
  • Coronavirus
  • OVX033
  • Saline solution
  • (no location specified)
Nov 14, 2023

Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)

Not yet recruiting
  • Iron Deficiency Anemia
  • Iron-fortified cookies
  • +3 more
  • (no location specified)
Aug 30, 2023

Tetanus Trial in Bijie (TTVA, TT)

Not yet recruiting
  • Tetanus
  • TTVA
  • TT
  • Bijie, Guizhou, China
    Center for Disease Control and Prevention, Qixingguan District,
Nov 7, 2023

Psoriasis Trial in Hefei (Secukinumab)

Recruiting
  • Psoriasis
  • Secukinumab
  • Hefei, Anhui, China
    The Second Hospital of Anhui Medical University
Feb 15, 2023

COVID-19, SARS-CoV-2 Infection Trial in United States (AZD9838, Licensed mRNA vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • AZD9838
  • Licensed mRNA vaccine
  • Long Beach, California
  • +4 more
Nov 24, 2023

Healthy Trial in Haikou (HS-20090, Xgeva®)

Not yet recruiting
  • Healthy
  • Haikou, Hainan, China
    Haikou People's Hospital
Mar 8, 2023

Malaria Trial (R21/Matrix-M™)

Recruiting
  • Malaria
  • R21/Matrix-M™
  • Entebbe, Uganda
    MRC/UVRI & LSHTM Uganda Research Unit
Jan 13, 2023

Assess Immunogenicity of Nationally Authorized Homologous

Not yet recruiting
  • COVID-19
  • Immune Responses
  • (no location specified)
Jan 31, 2023

Vaccine Reaction Trial in Jinhua, Quzhou (vaccinate with DTap, vaccinate with DT)

Not yet recruiting
  • Vaccine Reaction
  • vaccinate with DTap
  • vaccinate with DT
  • Jinhua, Zhejiang, China
  • +1 more
May 12, 2023

Vaccine Reaction Trial in Hangzhou, Jiaxing (vaccinate with DTaP, vaccinate with DT)

Not yet recruiting
  • Vaccine Reaction
  • vaccinate with DTaP
  • vaccinate with DT
  • Hangzhou, Zhejiang, China
  • +1 more
May 12, 2023

COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))

Completed
  • COVID-19
  • Recombinant Novel Coronavirus vaccine (CHO Cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 6, 2023